American Diversified Holdings Corporation (ADHC) Retains Bio Device Veteran, Bill Colone to Advise on Entering $585 Billion Bio Device Arena
American Diversified Holdings (OTC Pink: ADHC) announced the appointment of Bill Colone as an advisor for entry into the $585 billion bio device market. Colone, with over 40 years of experience and 13 US patents, has successfully guided companies through the FDA approval process. Currently, he holds senior roles at Med Edge Innovations, Indian Wells Medical, and is CEO of Single Pass, Inc., which recently received FDA approval for an electrocautery device. Colone aims to create shareholder value through acquisitions or strategic alliances.
- Appointment of Bill Colone, a seasoned expert with over 40 years in the medical device industry.
- Colone's successful track record with FDA approvals, including a recent approval for Single Pass, Inc.
- Entry into the lucrative $585 billion bio device market projected to grow at a 6.1% CAGR from 2022 to 2030.
- Potential for strategic acquisitions or alliances to increase shareholder value.
- No immediate financial benefits or revenue increases were announced.
- Dependence on future acquisitions or strategic alliances, which carries inherent risks.
- The success of the initiative is heavily reliant on Bill Colone's expertise, posing a risk if he departs.
Del Mar, California--(Newsfile Corp. - June 10, 2024) - American Diversified Holdings Corporation (OTC Pink: ADHC) announced today that Bill Colone has been brought on board to advise the company on its entrance into the
Mr. Colone brings a wealth of experience to the company having successfully navigated numerous companies through the FDA Approval process.
In addition to being an Independent Medical Device Consultant, Mr. Colone holds senior positions with Med Edge Innovations, Indian Wells Medical, Inc. and is the CEO of Single Pass, Inc.
Single Pass, Inc. recently met FDA approval for a electrocautery device used in biopsy procedures. See www.singlepass.co.
With over 40 years of experience with medical device development, he holds 13 US patents with many other applications pending.
"I look forward to working with the ADHC team to target opportunities in the bio device space. Bringing shareholder value to ADHC through an acquisition or strategic alliance is the primary goal. The ADHC public vehicle presents compelling opportunities for private bio device companies looking to grow and gain exposure," commented Mr. Colone.
About the Medical Device Market
A recent Alpha-Sense.com forecast projected the medical device market as overwhelmingly positive, with an expected global revenue of
See for more details
https://www.alpha-sense.com/blog/trends/medical-device-trends-outlook/
Bill Colone
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/211813_3de093cee4f35b40_001full.jpg
Bill Colone - Costa Mesa, California, United States | Professional Profile | LinkedIn
linkedin.com
BColone@SinglePass.co
About AMERICAN DIVERSIFIED HOLDINGS CORPORATION
Contact Details:
John Cacchioli, CEO
American Diversified Holdings Corporation
Telephone: (212) 537-5900
Email: JC@American-Diversified.com
Social Media:
TWITTER: @ADHCManagement.
This Twitter page is the only official Twitter page for ADHC.
SAFE HARBOR FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211813
FAQ
What is the significance of Bill Colone joining ADHC?
What market is ADHC targeting with Bill Colone's appointment?
What recent achievement does Bill Colone bring to ADHC?
What is the projected growth of the bio device market?
How does ADHC plan to bring shareholder value?
